961.385 Prescription drug monitoring program.
299 words·~1 min read·
/wi/chapter-961/961-385-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
961.385 Prescription drug monitoring program.
(1)In this section:
(a)“Administer” means the direct application of a monitored prescription drug, whether by injection, ingestion, or any other means, to the body of a patient by any of the following:
1. A practitioner or his or her agent.
2. A patient at the direction of a practitioner.
3. A pharmacist.
(ab)“Agent” means an authorized person who acts on behalf of or at the direction of another person.
(ac)“Board” means the controlled substances board.
(ad)“Business day” means any day on which the offices of the department of safety and professional services are open.
(ae)“Deliver” or “delivery” means the actual, constructive, or attempted transfer of a monitored prescription drug from one person to another.
(af)“Dispense” means to deliver a monitored prescription drug pursuant to the lawful prescription order of a practitioner, including the compounding, packaging, or labeling necessary to prepare the monitored prescription drug for delivery.
(ag)“Monitored prescription drug” means a substance identified in s. 961.16 , 961.18 , 961.20 , or 961.22 or a drug identified by the board by rule as having a substantial potential for abuse.
(aj)“Patient” means an individual or animal for whom a monitored prescription drug is prescribed or to whom a monitored prescription drug is dispensed or administered.
(aL)“Pharmacist” means a person licensed by the pharmacy examining board under s. 450.03 or 450.05 or licensed in another state and recognized by this state as a person authorized to engage in the practice of pharmacy in the state in which the person is licensed.
(an)“Pharmacy” means a place of practice licensed under s. 450.06 or 450.065 .
(ar)“Practitioner” has the meaning given in s. 450.01
(17)but does not include a veterinarian licensed under ch. 89 .